• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceABBOTT REALTIME HCV GENOTYPE II
Classification Nameassay, genotyping, hepatitis c virus
Generic Nameassay, genotyping, hepatitis c virus
Applicant
ABBOTT MOLECULAR
1300 east touhy avenue
des plaines, IL 60018
PMA NumberP120012
Supplement NumberS002
Date Received07/15/2013
Decision Date08/13/2013
Product Code
OBF[ Registered Establishments with OBF ]
Advisory Committee Microbiology
Supplement Type30-day notice
Supplement Reason process change - manufacturer/sterilizer/packager/supplier
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
CHANGE TO AN IN-PROCESS TEST METHOD FOR A COMPONENT OF THE ABBOTT REALTIME HCV GENOTYPE II.
-
-